|
VPS24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.720100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.436900E-03 |
| Normal-vs-Stage2 |
1.541580E-02 |
| Normal-vs-Stage3 |
2.816800E-03 |
| Normal-vs-Stage4 |
1.384190E-03 |
| Stage1-vs-Stage2 |
6.357400E-01 |
| Stage1-vs-Stage3 |
5.249600E-01 |
| Stage1-vs-Stage4 |
3.278000E-01 |
| Stage2-vs-Stage3 |
9.874600E-01 |
| Stage2-vs-Stage4 |
7.049200E-01 |
| Stage3-vs-Stage4 |
6.274400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.895250E-03 |
| Normal-vs-AfricanAmerican |
2.100200E-01 |
| Normal-vs-Asian |
6.749800E-02 |
| Caucasian-vs-AfricanAmerican |
3.441400E-01 |
| Caucasian-vs-Asian |
4.718200E-01 |
| AfricanAmerican-vs-Asian |
7.225400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.391300E-04 |
| Normal-vs-Female |
9.884500E-03 |
| Male-vs-Female |
7.970200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.039700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.438300E-03 |
| Normal-vs-Age(61-80Yrs) |
7.208600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.507700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.270000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.193200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.548200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.767400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.035200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.021600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.521600E-01 |
| Classical-VS-Follicular |
2.179600E-01 |
| Classical-VS-Other |
1.467750E-01 |
| Classical-VS-Normal |
1.405730E-02 |
| Tall-VS-Follicular |
7.812400E-01 |
| Tall-VS-Other |
2.301400E-01 |
| Tall-VS-Normal |
1.192130E-02 |
| Follicular-VS-Other |
4.788200E-01 |
| Follicular-VS-Normal |
4.178100E-03 |
| Other-VS-Normal |
1.764150E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.697780E-03 |
| Normal-vs-N1 |
1.396590E-03 |
| N0-vs-N1 |
3.842400E-01 |
|
|
